Abstract
West syndrome is infantile epileptic encephalopathy characterized by the triad of symptoms: infantile spasms, changes in the electroencephalogram (EEG) in the form of hypsarrhythmia and psychomotor retardation. Revealing of the predictors of clinical outcome can contribute to the selection of the optimal therapy and determine the terms of dynamic monitoring and improve treatment outcome.
 Aim: to identify predictors of West syndrome outcome.
 Materials and methods. The study included 132 patients who underwent treatment from 2000 to 2018. At the onset of the observation the age of children was from 5 months to 17 years 11 months. The age of the onset of spasms ranged from 1 day to 3 years 2 months. Depending on the etiological factor patients were divided into 3 groups: group 1 patients with a structural form (60 patients; 45.5%), group 2 patients with a genetic form (39 children; 29.5%), group 3 patients with the disease of unknown etiology (33 children; 25.0%). Evaluating the treatment, special attention was paid to the effectiveness of the first three lines of AEDs and hormones, as well as the further selection of AEDs.
 Results. Epileptic spasms were controlled in 76 children (57.6%), all seizures were controlled in 48 (36.4%) children. Patients of the 3rd group demonstrated a higher frequency of spasms arresting (87.9% in comparison to 48.7 and 46.7%) and complete remission (72.7% in comparison to 26.7 and 27.6% respectively). Normal neuropsychic development before the onset of spasms, the absence of epi-activity or the presence of regional epi-activity on the EEG in dynamics, the presence of diffuse changes in MRI had positive prognostic value for spasms control. Neonatal seizures, the presence of epi-activity on the EEG and focal deficiency before spasms, the presence of other seizures, pathology of vision and hearing, and necessity to use 2 drugs had negative prognostic value. The best compensation of motor and psychoverbal development was noted in patients who had remission.
 Conclusions. Predictors of negative outcome of West syndrome include structural and genetic forms of the disease, neonatal seizures, epi-activity on EEG, impaired neuropsychic development and the focal pathology before spasms, the presence of other seizures, the persistence of epi-activity in dynamics and the absence of the first-line therapy effect.
Highlights
■■ West syndrome is infantile epileptic encephalopathy characterized by the triad of symptoms: infantile spasms, changes in the electroencephalogram (EEG) in the form of hypsarrhythmia and psychomotor retardation
The age of the onset of spasms ranged from 1 day to 3 years 2 months
Epileptic spasms were controlled in 76 children (57.6%), all seizures were controlled in 48 (36.4%) children
Summary
Предикторы неблагоприятного исхода синдрома Веста // Аспирантский вестник Поволжья. Возраст дебюта спазмов варьировал от 1-х суток жизни до 3 лет 2 мес. Позитивное прогностическое значение для купирования спазмов имели: нормальное нервно-психическое развитие до дебюта спазмов, отсутствие эпиактивности или наличие региональной эпиактивности на ЭЭГ в динамике, наличие диффузных изменений на МРТ. Негативное прогностическое значение имели: неонатальные судороги, наличие эпиактивности на ЭЭГ и очагового дефицита до спазмов, наличие других приступов, кроме спазмов, патология зрения и слуха, необходимость применения ≥2 препаратов. Предикторами неблагоприятного исхода синдрома Веста можно считать: структурную и генетическую форму заболевания, неонатальные судороги, наличие эпилептиформной активности (ЭА) на ЭЭГ, нарушение нервно-психического развития и наличие очаговой патологии до спазмов, наличие других приступов кроме спазмов, сохранение ЭА в динамике, неэффективность терапии первой линии. ■■ Ключевые слова: синдром Веста; спазмы; ремиссия; эпилептиформная активность; предикторы исхода
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have